HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Antonis Chatzimichalis Gilbert Massard Jean-Marie Wihlm Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chatzimichalis, A. Articles by Wihlm, J.-M. Search for Related Content PubMed PubMed Citation Articles by Chatzimichalis, A. Articles by Wihlm, J.-M.

Ann Thorac Surg 1998;65:927-929
© 1998 The Society of Thoracic Surgeons

Bronchopulmonary Aspergilloma: A Reappraisal

^a Department of Thoracic Surgery, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Accepted for publication October 28, 1997.

Address reprint requests to Dr Massard, Department of Thoracic Surgery, Hôpitaux Universitaires de Strasbourg, F-67091 Strasbourg, France

Background. Classically, most complications observed after operations for aspergilloma occurred in patients with sequelae of tuberculosis. Because the incidence of tuberculosis has declined over the past two decades, aspergilloma is expected to develop with increasing frequency in patients without previous tuberculosis. Therefore, our hypothesis was that operative outcome should have improved during the most recent years in comparison with our previous experience.

Methods. Operative outcome of 12 recently accrued patients was evaluated and compared with a historic control group of 55 patients, previously reported by the same center.

Results. As expected, only 17% of patients of the present series had a history of tuberculosis, compared with 57% in the former series. Postoperatively, there was no mortality. Major morbidity has decreased, although this difference is not statistically significant: bleeding decreased from 44% to 9% of patients; space problems decreased from 47% to 18%; and prolonged hospital stay (>30 days) decreased from 32% to 9%.

Conclusions. Our results support a trend toward improved postoperative outcome of operations for aspergilloma owing to a decreased incidence of aspergilloma growing in tuberculous cavitations.

This article has been cited by other articles:

				A. Demir, M. Z Gunluoglu, A. Turna, H. V Kara, and S. I Dincer Analysis of Surgical Treatment for Pulmonary Aspergilloma Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 407 - 411. [Abstract] [Full Text] [PDF]

				I. C Kurul, S. Demircan, U. Yazici, T. Altinok, S. Topcu, and M. Unlu Surgical Management of Pulmonary Aspergilloma Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 320 - 323. [Abstract] [Full Text] [PDF]

				C. K. Park and S. Jheon Results of surgical treatment for pulmonary aspergilloma Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 918 - 923. [Abstract] [Full Text] [PDF]

				K. Al-Kattan, M. Ashour, W. Hajjar, M. Salah El Din, M. Fouda, and A. Al Bakry Surgery for pulmonary aspergilloma in post-tuberculous vs. immuno-compromised patients Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 728 - 733. [Abstract] [Full Text] [PDF]

				D. F. Blyth Pneumonectomy for inflammatory lung disease Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 429 - 434. [Abstract] [Full Text] [PDF]

				G. Babatasi, M. Massetti, A. Chapelier, E. Fadel, P. Macchiarini, A. Khayat, and P. Dartevelle Surgical treatment of pulmonary aspergilloma: Current outcome J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 906 - 912. [Abstract] [Full Text] [PDF]

				J.-F. Regnard, P. Icard, M. Nicolosi, L. Spagiarri, P. Magdeleinat, B. Jauffret, and P. Levasseur Aspergilloma: a series of 89 surgical cases Ann. Thorac. Surg., March 1, 2000; 69(3): 898 - 903. [Abstract] [Full Text] [PDF]